Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In this study we have tried to answer the following questions: (1) is it possible for different catabolite-repressible genes, although submitted to the same control, to be expressed selectively depending upon the growth conditions, and (2) what is the effect of increasing the osmolarity of the medium on the intracellular level of cAMP? Two conditions were found to cause a continuous variation of intracellular cAMP levels during growth. With different strains, higher cAMP levels are required for induction of the tryptophanase gene than one required for induction of the lactose operon. cAMP has been provided externally in
adenyl cyclase
minus cells of a mutant that has been made permeable by EDTA treatment. Although external cAMP concentrations, 10 times higher than the usual intracellular levels, are required for induction of
beta-galactosidase
and tryptophanase, the difference of requirements of cAMP is maintained. An increase in the osmolarity of the medium by sucrose addition causes a fourfold decrease in the intracellular cAMP level. As a consequence this prevents the induction of tryptophanase whereas
beta-galactosidase
is still inducible. After pulse induction, a difference in the kinetics of expression of the tryptophanase and
beta-galactosidase
genes was found. Its relationship with the previous results is discussed.
...
PMID:Different cyclic adenosine 3',5'-monophosphate requirements for induction of beta-galactosidase and tryptophanase. Effect of osmotic pressure on intracellular cyclic adenosine 3,5-monophosphate concentrations. 16 97
Two mutants are described in which the synthesis of tryptophanase is unusually insensitive to catabolite repression. Neither mutation is linked by transduction to the tryptophane structural gene, neither mutation renders the synthesis of
beta-galactosidase
insensitive to catabolite repression, and the mutations do not permit tryptophanase to be synthesized in strains deficient in
adenyl cyclase
. During growth in glucose-minimal medium the mutants maintained a similar intracellular concentration of cyclic AMP to their wild-type parent; but since in the wild type the concentration of cyclic AMP was the same in glycerol-minimal medium as in glucose-minimal medium, it is doubtful whether catabolite repression is mediated by measurable changes in the concentration of this nucleotide.
...
PMID:Mutations in Escherichia coli that relieve catabolite repression of tryptophanase synthesis. Mutations distant from the tryptophanase gene. 17 93
The regulation of catabolite repression of
beta-galactosidase
has been studied in Escherichia coli mutants deleted for the
adenyl cyclase
gene (cya delta), and thus unable to synthesize cyclic AMP. It has been found that, provided a second mutation occurs either in the crp gene coding for the catabolite gene activator protein (CAP) or in the Lactose region, these mutants exhibit catabolite repression. If the catabolite repression seen in the mutant strains corresponds to the mechanism operating in wild-type cells the results would suggest that the intracellular concentration of cyclic AMP cannot be the unique regulator of catabolite repression.
...
PMID:Catabolite repression in Escherichia coli mutants lacking cyclic AMP. 20 9
We have isolated a new class of mutations in rpoD, the gene encoding the sigma 70 subunit of Escherichia coli RNA polymerase, that alter the transcription initiation properties of RNA polymerase holoenzyme. The rpoD(Lac) mutations increase expression of the lac operon in the absence of CAP-cAMP, allowing a strain lacking
adenyl cyclase
to grow on lactose. Four of the six alleles isolated have three- to fivefold increases in the amount of lac mRNA and
beta-galactosidase
per cell. We show that these four mutations increase transcription initiation from the same promoter used by wild-type RNA polymerase. The mutations were mapped and sequenced. One mutation occurs in the codon for amino acid 389 of the sigma 70 polypeptide. The remaining five mutations are clustered, affecting residues 570, 571 and 575. These five mutations are within or near a proposed helix-turn-helix motif in the C terminus of sigma 70.
...
PMID:Mutations in rpoD, the gene encoding the sigma 70 subunit of Escherichia coli RNA polymerase, that increase expression of the lac operon in the absence of CAP-cAMP. 284 53